These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1911199)

  • 1. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer.
    van Oortmarssen GJ; Habbema JD
    Br J Cancer; 1991 Sep; 64(3):559-65. PubMed ID: 1911199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
    van Oortmarssen GJ; Habbema JD
    Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
    Coldman A; van Niekerk D; Smith L; Ogilvie G
    J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of dysplasia of the uterine cervix.
    Holowaty P; Miller AB; Rohan T; To T
    J Natl Cancer Inst; 1999 Feb; 91(3):252-8. PubMed ID: 10037103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer.
    Bergström R; Adami HO; Gustafsson L; Pontén J; Sparén P
    J Natl Cancer Inst; 1993 Jul; 85(13):1050-7. PubMed ID: 8515491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smear misclassification in a cervical cancer screening programme.
    Lynge E; Arffmann E; Poll P; Anderson PK
    Br J Cancer; 1993 Aug; 68(2):368-73. PubMed ID: 8347493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
    Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
    Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
    Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.
    Bos AB; van Ballegooijen M; van Oortmarssen GJ; van Marle ME; Habbema JD; Lynge E
    Br J Cancer; 1997; 75(1):124-30. PubMed ID: 9000609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.
    Anderson GH; Boyes DA; Benedet JL; Le Riche JC; Matisic JP; Suen KC; Worth AJ; Millner A; Bennett OM
    Br Med J (Clin Res Ed); 1988 Apr; 296(6627):975-8. PubMed ID: 3129115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forty years of repeated screening: the significance of carcinoma in situ.
    Morrison BJ; Coldman AJ; Boyes DA; Anderson GH
    Br J Cancer; 1996 Sep; 74(5):814-9. PubMed ID: 8795587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.